Jane L. Messina
- Oncology top 0.2%
- Molecular Biology top 2%
- Immunology top 1%
- Epidemiology top 1%
- Dermatology top 0.2%
- Co-authors
- Vernon K. SondakNeil A. FenskeJonathan S. ZagerL. Frank GlassKeiran S.M. SmalleyInna V. FedorenkoRichard HellerC. Wayne Cruse
- Topics
- Cutaneous Melanoma Detection and Management (108 papers)Melanoma and MAPK Pathways (61 papers)Nonmelanoma Skin Cancer Studies (51 papers)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Jane L. Messina
250 papers receiving 9.3k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Oncology 5.6k
- Molecular Biology 2.9k
- Immunology 2.1k
- Epidemiology 1.8k
- Dermatology 1.1k
Countries citing papers authored by Jane L. Messina
This map shows the geographic impact of Jane L. Messina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane L. Messina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane L. Messina more than expected).
Fields of papers citing papers by Jane L. Messina
This network shows the impact of papers produced by Jane L. Messina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane L. Messina. The network helps show where Jane L. Messina may publish in the future.
Co-authorship network of co-authors of Jane L. Messina
This figure shows the co-authorship network connecting the top 25 collaborators of Jane L. Messina. A scholar is included among the top collaborators of Jane L. Messina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane L. Messina. Jane L. Messina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 33 | |
| 4 | 3 | |
| 5 | 16 | |
| 6 | 96 | |
| 7 | 3 | |
| 8 | 26 | |
| 9 | 12 | |
| 10 | 111 | |
| 11 | 32 | |
| 12 | 85 | |
| 13 | 17 | |
| 14 | 51 | |
| 15 | 161 | |
| 16 | 57 | |
| 17 | 20 | |
| 18 | 406 | |
| 19 | Vesiculobullous variant of adult T-cell leukemia/lymphoma in a Caribbean Émigré. | 3 |
| 20 | Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanomabreakdown → | 503 |
About Jane L. Messina
Jane L. Messina is a scholar working on Oncology, Dermatology and Epidemiology, having authored 260 papers that have together received 9.6k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (108 papers), Melanoma and MAPK Pathways (61 papers) and Nonmelanoma Skin Cancer Studies (51 papers). The work is most often cited by research in Oncology (5.6k citations), Biological Psychiatry (364 citations) and Dermatology (1.1k citations). Jane L. Messina has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Vernon K. Sondak, Neil A. Fenske, Jonathan S. Zager, L. Frank Glass, Keiran S.M. Smalley, Inna V. Fedorenko, Richard Heller, C. Wayne Cruse, Douglas S. Reintgen and Adam I. Riker. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.